000 007430000a22001810004500
001 12382
090 _a12382
100 _a20090915d k||y0pory50 ba
101 _aeng
102 _aUS
200 _aMicrobiologic, clinical, and economic outcomes of dual individualized dosing of antimicrobial agents
_fJoseph A. Paladino, Jerome J. Schentag
300 _aCapítulo de monografia
463 _aMichael E. Burton... [et al.]
_cPhiladelphia
_d2006
_e4th ed
_nLippincott Williams & Wilkins
_pp. 341-353
_tApplied pharmacokinetics and pharmacodynamics : principles of therapeutic drug monitoring
_05040
606 _91377
_aFarmacocinética
606 _91378
_aFarmacodinâmica
676 _a615.7 B98a
_v4ª ed.
700 _923330
_aPaladino
_bJoseph A.
701 _926691
_4070
_aSchentag
_bJerome J.
942 _cANA
_n0